CT冠状动脉造影可替代有创冠状动脉造影用于二尖瓣手术术前评估
该单中心回顾性队列研究纳入1576例二尖瓣手术患者,经1:2倾向性评分匹配比较CTA组(n=345)与ICA组(n=602)的术后主要不良事件复合终点。
要点
- 低危择期二尖瓣手术患者术前用CTA评估冠状动脉,主要不良事件风险与ICA相当。
- 基于该数据,研究机构已将冠状动脉CTA用于所有低危择期患者的术前评估。
核心结论
- 低危择期二尖瓣手术患者术前用CTA评估冠状动脉,主要不良事件风险不高于ICA。
研究设计与样本
- 单中心回顾性队列研究,数据收集自2014年7月至2020年6月,纳入1576例二尖瓣手术患者,排除需行冠状动脉旁路移植术者。
- 采用1:2倾向性评分匹配,CTA组345例,ICA组602例。
主要发现
- CTA组平均年龄55.62岁(标准差11.54),ICA组58.22岁(标准差10.11)。
- CTA组334例(96.8%)和ICA组582例(96.7%)行二尖瓣修复。
- CTA组术后卒中4例(1.2%),ICA组3例(0.5%);CTA组术后需肾脏替代治疗1例(0.3%),ICA组11例(1.8%)。
临床怎么用
- 对于低危择期二尖瓣手术患者,可考虑用冠状动脉CTA替代ICA进行术前冠状动脉评估。
局限性
- 本研究为单中心回顾性队列研究,结论需前瞻性研究进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the effectiveness of noninvasive coronary computed tomography angiography (CTA) as an alternative to traditional invasive coronary angiography (ICA) for preoperative evaluation of low-risk patients with an indication for nonemergent mitral surgery and to assess any difference in adverse outcomes from this strategy. METHODS: This was a retrospective cohort study from a single center with data collected from July 2014 to June 2020 for 1576 patients undergoing mitral valve surgery of all etiologies, excluding patients requiring coronary artery bypass surgery. We performed a 1:2 propensity score matching for patients evaluated with CTA (n = 345) to those evaluated with ICA (n = 602). The primary outcome was a composite of major adverse events in the immediate postoperative period, including death, stroke, new-onset renal failure, postoperative cardiac arrest, need for unplanned coronary artery bypass grafting or percutaneous coronary re-vascularization. The odds ratio was calculated for occurrence of major adverse events in the CTA group compared with the catheterization group. RESULTS: The mean age (standard deviation) was 55.62 years (11.54) for the CTA group and 58.22 years (10.11) for the ICA group. In the CTA group 334 (96.8%) and from the ICA group 582 (96.7%) patients underwent mitral valve repair. Thirteen (3.8%) patients in the CTA group experienced a major adverse event compared with 25 (4.2%) patients in the ICA group. Of these, there were no mortalities in the CTA group but 1 (0.2%) operative mortality in the ICA group. Four (1.2%) patients in the CTA group had a postoperative stroke compared with 3 (0.5%) patients in the ICA group. One (0.3%) patient in the CTA group required renal-replacement therapy postoperatively compared with 11 (1.8%) in the ICA group. Percutaneous coronary intervention was required in 1 (0.3%) patient in CTA group and 2 (0.3%) patients in ICA group for a coronary complication of valve surgery despite nonobstructive coronary anatomy being confirmed in both groups preoperatively. The odds ratio for having a major adverse event when worked up by CTA compared with ICA was 0.904 (0.443, 1.761). CONCLUSIONS: There were no increased odds of experiencing a major adverse event for low-risk patients undergoing elective mitral valve surgery and preoperative coronary evaluation with CTA compared with ICA. These data have modified our practice pattern, where we now offer coronary CTA to all elective patients who are low risk for coronary artery disease.
引用
- Patil AR, Zheng A, Israel Y, et al. Computed tomography coronary angiography as an alternative to invasive coronary angiography in preoperative evaluation for mitral surgery. J Thorac Cardiovasc Surg. 2025. PMID: 39837408. doi:10.1016/j.jtcvs.2024.12.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。